Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-728K
-
Total reported value, excl. options
-
$776M
-
Value change
-
-$31.4M
-
Put/Call ratio
-
0.73
-
Number of buys
-
96
-
Number of sells
-
-59
-
Price
-
$41.30
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q1 2021
200 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 27.2M outstanding shares and own 69.14% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (3.33M shares), FEDERATED HERMES, INC. (3.2M shares), BlackRock Inc. (1.75M shares), STATE STREET CORP (1.4M shares), ORBIMED ADVISORS LLC (1.21M shares), VANGUARD GROUP INC (1.2M shares), FMR LLC (730K shares), Bank Julius Baer & Co. Ltd, Zurich (416K shares), TWO SIGMA INVESTMENTS, LP (393K shares), and GEODE CAPITAL MANAGEMENT, LLC (356K shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.